0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Jose Ramon Maneiro, MD; Eva Salgado, MD; Juan Jesus Gomez-Reino, PhD
JAMA Intern Med. 2013;173(15):1416-1428. doi:10.1001/jamainternmed.2013.7430.
Includes: Supplemental Content

Editor's Correspondence | 
George Larios, MD, MSc; Alevizos Alevizos, MD; Dimitris Rigopoulos, MD, PhD
Arch Intern Med. 2008;168(6):666. doi:10.1001/archinte.168.6.666.

Original Investigation |  FREE
Arathi R. Setty, MD, MPH; Gary Curhan, MD, ScD; Hyon K. Choi, MD, DrPH
Arch Intern Med. 2007;167(15):1670-1675. doi:10.1001/archinte.167.15.1670.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Dermatology
Research Letter  | 
Excess Adiposity Preceding Pediatric Psoriasis
Lauren Becker, MD; Wynnis L. Tom, MD; Karin Eshagh; et al.
JAMA Dermatology
Invited Commentary  | 
Preventing and Detecting Antibodies to Anti–Tumor Necrosis Factor Agents:  Gaps in Practice or in Evidence?
Kristina Callis Duffin, MD, MS
JAMA Dermatology
Original Investigation  | 
Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis:  One-Year Follow-up
Stef P. Menting, MD; Paula P. M. van Lümig, MD; Anna-Christa Q. de Vries, MD; et al.
JAMA Dermatology
Case Report/Case Series  | 
Ustekinumab Associated With Flares of Psoriatic Arthritis
Emily F. Stamell, MD; Allison Kutner, BA; Kate Viola, MD; et al.